The challenge of p53 as prognostic and predictive factor in gliomas
- 29 February 2000
- journal article
- research article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 26 (1), 67-73
- https://doi.org/10.1053/ctrv.1999.0145
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Combined radiation and p53 gene therapy of malignant glioma cellsCancer Gene Therapy, 1999
- P53 function influences the effect of fractionated radiotherapy on glioblastoma tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1999
- Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stressOncogene, 1998
- The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21 BAX expressionProceedings of the National Academy of Sciences of the United States of America, 1998
- The functional role of tumor suppressor genes in gliomasNeurology, 1998
- The p53 tumour suppressor geneBritish Journal of Surgery, 1998
- A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomasEuropean Journal Of Cancer, 1998
- Association ofp53 gene mutation with decreased chemosensitivity in human malignant gliomasInternational Journal of Cancer, 1996
- The basis for current treatment recommendations for malignant gliomasJournal of Neuro-Oncology, 1994
- Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final reportInternational Journal of Radiation Oncology*Biology*Physics, 1990